Skip to content

Analgesic Efficacy of Ultrasound Guided Bilateral Erector Spinae Plane Block in Pediatric.

Analgesic Efficacy of Ultrasound Guided Bilateral Erector Spinae Plane Block Versus Fentanyl Infusion in Pediatric Patients Undergoing Cardiac Surgeries. a Randomized Controlled Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04452656
Enrollment
98
Registered
2020-06-30
Start date
2020-07-20
Completion date
2021-08-15
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Anesthesia, Local

Keywords

Erector spinae plane block, Pediatric, sternotomy

Brief summary

This randomized, double-blinded, study aims to compare the efficacy of analgesia and any side effects of U/S guided bilateral Erector SpinaePlane block versus non-block t paediatric patients undergoing corrective cardiac surgeries.

Detailed description

Our study will be designed to estimate and compare the analgesic effect of single shotbilatral erector spinae plane block in pediatric patients undergoing corrective cardiac surgeries versus non-block as the control group. Our primary outcome will be the total dose of intraoperative fentanyl boluses. Randomization will be achieved by using an online random number generator. Patient codes will be placed into sequentially numbered sealed opaque envelopes by a research assistant who is not involved in the study. A medical personnel not involved in patient management will be responsible for opening the envelope and give the instructions contained within each envelope to the anesthesiologist who is expert in doing the ESP block in patients included within the block group. The anesthesia team who managed the patients intraoperatively did not share in recording data for the research. However, another physcian will be responsible for recording the intraoperative data.

Interventions

An ultrasound transducer will be placed in a longitudinal orientation 3 cm lateral to the T3 spinous process corresponding to the T2 transverse process. Three muscles; trapezius , rhomboids major , and erector spinae will be identified superior to the hyperechoic transverse process. Using in-plane approach a 25 G needle will be inserted in caudal-cephalad direction, until the tip is deep to erector spinae muscle. Correct needle tip location will be confirmed by injecting 3 mL of saline and visualizing the linear LA spread in the fascial plane between the erector spinae muscle and the transverse process.. 0.4 ml/kg (1:1 solution of bupivacaine 0.25% and lidocaine 1%) will be injected and visualizing the linear LA spread in the fascial plane between the erector spinae muscle andthe transverse process12.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Blindness will be achieved by patient codes which will be placed into sequentially numbered sealed opaque envelopes by a research assistant who is not involved in the study. A physician not involved in patient management will be responsible for opening the envelope and give the instructions contained within each envelope to the anaesthesiologist who is expert in doing the Erector spinae plane block in patients included within the block group. This expert anaesthesiologist will not be involved in collecting data but another anaesthesia doctor will be responsible for patient management and collecting the intraoperative and postoperative data.

Eligibility

Sex/Gender
ALL
Age
6 Months to 7 Years
Healthy volunteers
No

Inclusion criteria

* Age:6 months-7 years. * ASA, American Society of Anesthesiology, II and III . * Patients undergoing cardiac surgeries with midline sternotomy incision.

Exclusion criteria

* Patients whose parents or legal guardians refusing to participate. * Preoperative mechanical ventilation. * Preoperative inotropic drug infusion. * Known or suspected coagulopathy. * Any congenital anomalies of the sacrum/the vertebral column or any infection at the site of injection. * Known or suspected allergy to any of the studied drugs. * Elevated liver enzymes more than the normal values. * Renal function impairment (Creatinine value more than 1.2 mg/dl or BUN more than 20mg/dl).

Design outcomes

Primary

MeasureTime frameDescription
The total dose of intraoperative fentanyl boluses in microgram.3 monthsThe total dose of intraoperative fentanyl boluses in microgram

Secondary

MeasureTime frameDescription
Pain assessment at postoperatively by FLACC score3 monthsPain assessment postoperatively by FLACC score
Total consumption of morphine during the first 24 hours postoperatively.3 montsTotal consumption of morphine during the first 24 hours postoperatively
extubation time3 monthstime from finishing skin incision suturing and cessation of anesthesia to successful removal of endotracheal tube.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026